CNKI, China National Knowledge Infrastructure

  • 文章类型: Journal Article
    UNASSIGNED:我们确定了中医(TCM)中正常高血压病的体质类型的分布,并为预防正常高血压病和高血压提供了证据。
    UNASSIGNED:从2011年1月到2022年11月搜索了八个数字数据库,包括PubMed,EMBASE,WebofScience,EBSCOhost,CNKI,CBM,王芳,还有CQVIP.我们使用随机效应模型或固定效应模型进行了荟萃分析,以描述中医正常高血压的构成类型的分布。这些研究是根据异质性测试和发表偏倚的可能性进行评估的。Meta分析在Stata软件15.0上进行。
    UNASSIGNED:本荟萃分析共纳入17项研究,共8118名参与者。偏体质的比例(82.3%;95%CI:75.6%-89.1%,p<0.001)高于平衡体质(17.3%;95%CI:10.7-23.8%,p<0.001)。痰湿体质,阴虚体质,湿热体质占16.0%(95CI:10.5-21.5%,p<0.001),14.8%(95%CI:11.0-18.6%,p<0.001),11.3%(95%CI:8.0-14.5%,p<0.001)的正常高血压病例总数,分别。亚组分析执行了该区域,年龄和性别与中医正常高值血压的体质类型分布呈正相关。与普通人群相比,痰湿体质的人血压正常偏高的风险,阴虚体质,血瘀体质为2.665(95CI:2.286-3.106,p<0.001),2.378(95CI:1.197-4.724,p=0.013),普通人群的1.965(95CI:1.634-2.363,p<0.001)倍,分别。同时,体质平衡的人群出现正常高值血压的风险较低(0.248,95CI:0.165-0.372,p<0.001).
    未经批准:痰湿体质,阴虚体质,湿热体质是正常高血压的常见体质类型。不同地区正常高值血压人群的中医体质分布特征也可能存在差异,年龄,和性别。最后,平衡的体质可能是高血压患者的保护因素。
    UNASSIGNED: We determined the distribution of constitutional types of high-normal blood pressure in Traditional Chinese Medicine (TCM) and provided evidence for the prevention of high-normal blood pressure and hypertension.
    UNASSIGNED: Eight digital databases were searched from January 2011 to November 2022, including PubMed, EMBASE, Web of Science, EBSCOhost, CNKI, CBM, Wangfang, and CQVIP. We performed a meta-analysis with the random-effects model or fixed-effects model to describe the distribution of constitutional types of high-normal blood pressure in TCM. The studies were assessed based on heterogeneity testing and the potential for publication bias. The meta-analysis was performed on Stata software 15.0.
    UNASSIGNED: A total of 17 studies with 8118 participants were included in this meta-analysis. The proportion of the biased constitution (82.3%; 95% CI: 75.6%-89.1%, p < 0.001) was higher than the balanced constitution (17.3%; 95% CI: 10.7-23.8%, p < 0.001). Phlegm-dampness constitution, Yin-deficiency constitution, and damp-heat constitution accounted for 16.0% (95%CI: 10.5-21.5%, p < 0.001), 14.8% (95% CI: 11.0-18.6%, p < 0.001), 11.3% (95% CI: 8.0-14.5%, p < 0.001) of the total high-normal blood pressure cases, respectively. The subgroup analyses performed that region, age and gender were positively associated with the distribution of constitution types of high-normal blood pressure in TCM. Compared with the general population, the risk of high-normal blood pressure in people with the phlegm-dampness constitution, Yin-deficiency constitution, and blood-stasis constitution was 2.665 (95%CI: 2.286-3.106, p < 0.001), 2.378 (95%CI: 1.197-4.724, p = 0.013), 1.965 (95%CI: 1.634-2.363, p < 0.001) times of the general population, respectively. Meanwhile, the risk of high-normal blood pressure was lower in people with a balanced constitution (0.248, 95%CI: 0.165-0.372, p < 0.001).
    UNASSIGNED: Phlegm-dampness constitution, Yin-deficiency constitution, and damp-heat constitution were the common constitution types of high-normal blood pressure. There might also be differences in the distribution characteristics of TCM constitution among people with high-normal blood pressure in different regions, ages, and genders. Finally, a balanced constitution might be a protective factor for hypertensive people.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    未经评估:/目标:洪水风险是一个全球性问题,并且已经建立了各种方法来防止世界各地的洪水风险。中国是受洪水影响严重的国家之一,自2015年以来一直在实施海绵城市计划以抵御洪水。不幸的是,近年来,洪水在中国很普遍,给公民带来严重的健康风险。本研究主要集中在(a)评估中国海绵城市计划的实施及其对人类健康的相关影响,以及(b)探索中国海绵城市计划的未来改进。
    UNASSIGNED:使用解释性文件方法来探索对海绵城市计划及其对人类健康的影响的包容性审查。
    UNASSIGNED:/调查结果:中国的海绵城市计划仍然不足以有效预防洪水风险。在过去的八年里,24/34省份记录了洪水,共造成4701人死亡,经济损失超过5255亿元人民币(约合729亿美元)。到现在为止,只有64/654个城市颁布了管理海绵城市建设的地方立法,尽管海绵城市在2015年实施。此外,已完成的海绵城市计划建设不能完全防止洪水风险,防洪能力有限。海绵城市计划不被授予优先权,缺乏国家立法阻碍了海绵城市计划在中国的实施。
    UNASSIGNED:中国需要就海绵城市计划制定国家立法,并更新海绵城市计划技术指南。地方政府应根据当地地理环境实施海绵城市建设。
    UNASSIGNED: /Objective: Flooding risk is a global issue, and various approaches have been established to prevent flooding risk around the world. China is one of the heavily flood-affected countries and has been implementing the Sponge City program since 2015 to defend against flooding. Unfortunately, flooding has been common in China in recent years, causing severe health risks to citizens. This research mainly focuses on (a) evaluating the implementation of China\'s Sponge City program and the associated impacts on human health and (b) exploring the future improvement of the Sponge City program in China.
    UNASSIGNED: The Interpretive Document Approach was used to explore an inclusive review of the Sponge City program and its implications on human health.
    UNASSIGNED: /Findings: The Sponge City program in China is still insufficient to prevent flooding risks effectively. In the past eight years, 24/34 provinces have recorded flooding, which caused a total of 4701 deaths and over 525.5 billion RMB (around 72.9 billion US$) in economic loss. Till now, only 64/654 cities have promulgated local legislation to manage sponge city construction, although the Sponge City was implemented in 2015. Besides, the completed Sponge City program constructions cannot fully prevent flooding risks, the flood prevention capacity is limited. The Sponge City program is not granted priority, lacking national legislation hinders Sponge City program implementation in China.
    UNASSIGNED: China needs to make national legislation on the Sponge City program and update the Sponge City program technology guidelines. Local governments should implement Sponge City construction according to local geographic environments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    The use of herbs to treat various human diseases has been recorded for thousands of years. In Asia\'s current medical system, numerous herbal formulas have been repeatedly verified to confirm their effectiveness in different periods, which is a great resource for drug innovation and discovery. Through the mining of these clinical effective formulas by network pharmacology and bioinformatics analysis, important biologically active ingredients derived from these natural products might be discovered. As modern medicine requires a combination of multiple drugs for the treatment of complex diseases, previously clinical formulas are also combinations of various herbs according to the main causes and accompanying symptoms. However, the herbs that play a major role in the treatment of diseases are always unclear. Therefore, how to rank each herb\'s relative importance and determine the core herbs, is the first step to assisting herb selection for active ingredients discovery. To solve this problem, we built the platform FangNet, which ranks all herbs on their relative topological importance using the PageRank algorithm, based on the constructed symptom-herb network from a collection of clinical empirical prescriptions. Three types of herb hidden knowledge, including herb importance rank, herb-herb co-occurrence, and associations to symptoms, were provided in an interactive visualization. Moreover, FangNet has designed role-based permission for teams to store, analyze, and jointly interpret their clinical formulas, in an easy and secure collaboration environment, aiming at creating a central hub for massive symptom-herb connections. FangNet can be accessed at http://fangnet.org or http://fangnet.herb.ac.cn.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    临床研究表明,2019年冠状病毒病(COVID-19)患者的肾损伤一直是一个真正的问题,这与高死亡率和炎症/凋亡相关的因果关系有关。目前还开发了针对肾损伤的有效靶向治疗。此外,据报道,潜在的抗COVID-19药物也会对肾脏造成不良副作用。中草药(CHM),然而,在治疗肾损伤方面具有丰富的经验,并在中国的COVID-19战斗中成功应用。然而,CHM治疗的分子机制尚不清楚.在这项研究中,我们广泛检索了治疗肾损伤的处方,并研究了治疗COVID-19相关肾损伤的潜在机制.关联规则分析表明,核心草药包括黄琦,傅玲,白竹,黄迪,山瑶。中草药调节核心途径,比如年龄-愤怒,PI3K-AKT,TNF与细胞凋亡通路,等。成分(槲皮素,福蒙素,山奈酚,等。,)来自核心草药可以调节靶标(PTGS2(COX2),PTGS1(COX1),IL6、CASP3、NOS2和TNF,等。),从而预防与COVID-19感染相当的药理和非药理肾损伤。这项研究提供了CHM对抗COVID-19相关肾损伤以减少并发症和死亡率的治疗潜力。
    Clinical studies have shown that renal injury in Corona Virus Disease 2019 (COVID-19) patients has been a real concern, which is associated with high mortality and an inflammation/apoptosis-related causality. Effective target therapy for renal injury has yet been developed. Besides, potential anti-COVID-19 medicines have also been reported to cause adverse side effects to kidney. Chinese Herbal Medicine (CHM), however, has rich experience in treating renal injury and has successfully applied in China in the battle of COVID-19. Nevertheless, the molecular mechanisms of CHM treatment are still unclear. In this study, we searched prescriptions in the treatment of renal injury extensively and the potential mechanisms to treat COVID-19 related renal injury were investigated. The association rules analysis showed that the core herbs includes Huang Qi, Fu Ling, Bai Zhu, Di Huang, Shan Yao. TCM herbs regulate core pathways, such as AGE-RAGE, PI3K-AKT, TNF and apoptosis pathway, etc. The ingredients (quercetin, formononetin, kaempferol, etc.,) from core herbs could modulate targets (PTGS2 (COX2), PTGS1 (COX1), IL6, CASP3, NOS2, and TNF, etc.), and thereby prevent the pharmacological and non-pharmacological renal injury comparable to that from COVID-19 infection. This study provides therapeutic potentials of CHM to combat COVID-19 related renal injury to reduce complications and mortality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    许多研究已经获得了eNOS-4b/a多态性与2型糖尿病受试者中糖尿病肾病(DN)风险之间的关联。然而,结果是相互矛盾和不确定的。当前荟萃分析的目的是更精确地估计这种关系。Pubmed,Embase,在中国国家知识基础设施和万方数据库中搜索了截至5月26日发表的文章,2013年,研究了eNOS-4b/a多态性和2型糖尿病受试者的DN风险。该荟萃分析包括18项研究。eNOS-4b/a多态性与DN总体风险显著增加相关(等位基因模型:OR=1.44,95%CI=1.14-1.82;加性模型:OR=2.03,95%CI=1.14-3.62;显性模型:OR=1.34,95%CI=1.07-1.68;隐性模型:OR=2.01,95%CI=1.12-3.61)。亚组分析显示,亚洲人群中eNOS-4b/a多态性与DN之间存在显着关联。尤其是在中国人口中,但不是在非亚洲人群中。我们的荟萃分析支持eNOS基因的4b/a多态性与亚洲人2型糖尿病的DN风险增加之间的关联。尤其是在中国人口中。
    Many studies have accessed the association between eNOS-4b/a polymorphism and the risk of diabetic nephropathy (DN) among type 2 diabetic subjects. However, the results are conflicting and inconclusive. The aim of current meta-analysis was to more precisely estimate the relationship. Pubmed, Embase, the China National Knowledge Infrastructure and the Wanfang Database were searched for articles published up to May 26th, 2013 that addressed eNOS-4b/a polymorphism and the risk of DN among type 2 diabetic subjects. 18 studies were included in this meta-analysis. eNOS-4b/a polymorphisms were associated with an overall significantly increased risk of DN (allele model: OR = 1.44, 95% CI = 1.14-1.82; additive model: OR = 2.03, 95% CI = 1.14-3.62; dominant model: OR = 1.34, 95% CI = 1.07-1.68; recessive model: OR = 2.01, 95% CI = 1.12-3.61). Subgroup analysis revealed a significant association between the eNOS-4b/a polymorphism and DN in Asian population, especially in Chinese population, but not in non Asian populations. Our meta-analysis supported an association between the 4b/a polymorphism of eNOS gene and increased risk of DN in type 2 diabetes among Asians, especially in Chinese population.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号